Radiation and immunotherapy join forces in new cancer trial

NCT ID NCT07277777

Not yet recruiting Disease control Sponsor: Li Min Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding a special type of radiation (called 125I seed brachytherapy) to standard immunotherapy can help shrink tumors and keep them from growing back. The trial will include 90 adults with various cancers that have come back or spread. Half will get the combination treatment, and half will get immunotherapy alone. The goal is to see if the radiation makes the immune system work better against the cancer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The 960th Hospital of People's Liberation Army (PLA)

    Jinan, Shandong, 250031, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.